Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19
- Authors:
- Periklis Katopodis
- Vladimir Anikin
- Harpal S. Randeva
- Demetrios A. Spandidos
- Kamaljit Chatha
- Ioannis Kyrou
- Emmanouil Karteris
View Affiliations
Affiliations: Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge UB8 3PH, UK, Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Department of Biochemistry and Immunology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK
- Published online on: May 26, 2020 https://doi.org/10.3892/ijo.2020.5071
-
Pages:
533-539
-
Copyright: © Katopodis
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Severe acute respiratory syndrome (SARS) coronavirus‑2 (SARS‑CoV2) is the cause of a new disease (COVID‑19) which has evolved into a pandemic during the first half of 2020. Older age, male sex and certain underlying diseases, including cancer, appear to significantly increase the risk for severe COVID‑19. SARS‑CoV‑2 infection of host cells is facilitated by the angiotensin‑converting enzyme 2 (ACE‑2), and by transmembrane protease serine 2 (TMPRSS2) and other host cell proteases such as cathepsin L (CTSL). With the exception of ACE‑2, a systematic analysis of these two other SARS‑CoV2 infection mediators in malignancies is lacking. Here, we analysed genetic alteration, RNA expression, and DNA methylation of TMPRSS2 and CTSL across a wide spectrum of tumors and controls. TMPRSS2 was overexpressed in cervical squamous cell carcinoma and endocervical adenocarcinoma, colon adenocarcinoma, prostate adenocarcinoma (PRAD), rectum adenocarcinoma (READ), uterine corpus endometrial carcinoma and uterine carcinosarcoma, with PRAD and READ exhibiting the highest expression of all cancers. CTSL was upregulated in lymphoid neoplasm diffuse large B‑cell lymphoma, oesophageal carcinoma, glioblastoma multiforme, head and neck squamous cell carcinoma, lower grade glioma, pancreatic adenocarcinoma, skin cutaneous melanoma, stomach adenocarcinoma, and thymoma. Hypo‑methylation of both genes was evident in most cases where they have been highly upregulated. We have expanded on our observations by including data relating to mutations and copy number alterations at pan‑cancer level. The novel hypotheses that are stemming out of these data need to be further investigated and validated in large clinical studies.
View Figures |
Figure 1
|
 |
Figure 2
|
 |
Figure 3
|
 |
Figure 4
|
 |
Figure 5
|
 |
Figure 6
|
 |
Figure 7
|
 |
Figure 8
|
 |
Figure 9
|
View References
|
1
|
Yuki K, Fujiogi M and Koutsogiannaki S:
COVID-19 patho-physiology: A review. Clin Immunol. 215:1084272020.
View Article : Google Scholar
|
|
2
|
Hoffmann M, Kleine-Weber H, Schroeder S,
Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H,
Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2
and is blocked by a clinically proven protease inhibitor. Cell.
181:271–280.e8. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smieszek SP, Przychodzen BP and
Polymeropoulos MH: Amantadine disrupts lysosomal gene expression: A
hypothesis for COVID19 treatment. Int J Antimicrob Agents. Apr
30–2020.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sidaway P: COVID-19 and cancer: What we
know so far. Nat Rev Clin Oncol. Apr 7–2020.Epub ahead of print.
View Article : Google Scholar
|
|
5
|
Chai P, Yu J, Ge S, Jia R and Fan X:
Genetic alteration, RNA expression, and DNA methylation profiling
of coronavirus disease 2019 (COVID-19) receptor ACE2 in
malignancies: A pan-cancer analysis. J Hematol Oncol. 13:432020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Filella X and Foj L: Prostate Cancer
Detection and Prognosis: From Prostate Specific Antigen (PSA) to
Exosomal Biomarkers. Int J Mol Sci. 17:17842016. View Article : Google Scholar :
|
|
7
|
Kong Q, Xiang Z, Wu Y, Gu Y, Guo J and
Geng F: Analysis of the susceptibility of lung cancer patients to
SARS-CoV-2 infection. Mol Cancer. 19:802020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stopsack KH, Mucci LA, Antonarakis ES,
Nelson PS and Kantoff PW: TMPRSS2 and COVID-19: Serendipity or
opportunity for intervention? Cancer Discov. Apr 10–2020.Epub ahead
of print. View Article : Google Scholar
|
|
9
|
Liu F, Long X, Zhang B, Zhang W, Chen X
and Zhang Z: ACE2 expression in pancreas may cause pancreatic
damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. Apr
22–2020.Epub ahead of print. View Article : Google Scholar :
|
|
10
|
Li M, Chen L, Zhang J, Xiong C and Li X:
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface
and fetal organs by single-cell transcriptome study. PLoS One.
15:e02302952020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stumpfe FM, Titzmann A, Schneider MO,
Stelzl P, Kehl S, Fasching PA, Beckmann MW and Ensser A: SARS-CoV-2
infection in pregnancy - a review of the current literature and
possible impact on maternal and neonatal outcome. Geburtshilfe
Frauenheilkd. 80:380–390. 2020.In German. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBio-Portal. Sci Signal. 6:l12013. View Article : Google Scholar
|
